Tumor size reduction and serum CA 19-9 kinetics as metrics of resectability and response following neoadjuvant folfirinox in patients with pancreatic ductal adenocarcinoma.

Saved in:
Bibliographic Details
Title: Tumor size reduction and serum CA 19-9 kinetics as metrics of resectability and response following neoadjuvant folfirinox in patients with pancreatic ductal adenocarcinoma.
Authors: Servin-Rojas, M.1 (AUTHOR), Qiao, G.1 (AUTHOR), Ferrone, C.R.1 (AUTHOR), Fernandez-Del Castillo, C.1 (AUTHOR), Hang, L.1 (AUTHOR), Rocha-Castellanos, D.1 (AUTHOR), Fong, Z.V.1 (AUTHOR), Lillemoe, K.D.1 (AUTHOR), Qadan, M.1 (AUTHOR)
Source: HPB (1365-182X). 2023 Supplement 1, Vol. 25, pS20-S21. 2p.
Database: Academic Search Ultimate
Description
ISSN:1365182X
DOI:10.1016/j.hpb.2023.05.044